Company AB Science

AB

FR0010557264

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-16 EDT			After hours 14:55:02
0.6180 ^EUR	-4.19%		0.6160	-0.32%

07-01	AB Science, successful private placement
06-30	AB Science S.A. announced that it has received ?2.294 million in funding	CI

Business description: AB Science

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 31

Sales by Activity: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Pharmaceuticals	1.61M	958K	970K	1.07M	1.17M

See all business segments

Geographical breakdown of sales: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Europe	-	-	-	-	955K
outside Europe	-	-	-	-	219K

See all geographic segments

Executive Committee: AB Science

Manager	Title	Age	Since
Stéphane Ledermann CEO	Chief Executive Officer	-	2026-07-06
Laurent Guy DFI	Director of Finance/CFO	-	2009-11-19
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	2018-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

See AB SCIENCE governance

Composition of the Board of Directors: AB Science

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	2001-07-10
Patrick Moussy BRD	Director/Board Member	-	2011-09-19
Cécile de Guillebon BRD	Director/Board Member	64	2021-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	68	2021-06-26
Guillemette Latscha BRD	Director/Board Member	-	2021-06-26
Stéphane Ledermann CHM	Chairman	-	2026-07-06

Composition of the Board of Directors

Shareholders: AB Science

Name	Stocks	%	Valuation
UBS Wealth Management SGIIC SA 0.004443 %	3,100	0.004443 %	3 137 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 5.198 %	85,471	5.198 %	32 638 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 4.167 %	64,103	4.167 %	20 081 €

List of AB SCIENCE shareholders

Company details: AB Science

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AB SCIENCE	-4.19%	-17.60%	-51.94%	-84.21%	59.03M
MERCK & CO., INC.	+3.63%	+2.59%	+55.66%	+21.54%	305B
MERCK KGAA	-1.53%	-1.18%	+24.90%	-7.29%	69.67B
HALOZYME THERAPEUTICS, INC.	+2.31%	-1.35%	+33.70%	+92.60%	8.99B
KYOWA KIRIN CO., LTD.	+0.23%	-1.27%	+6.72%	-0.25%	8.52B
BETTA PHARMACEUTICALS CO., LTD.	-3.05%	+4.98%	+10.85%	+28.13%	4.17B
SK BIOPHARMACEUTICALS CO., LTD.	+1.53%	-3.29%	-19.72%	+3.79%	4.11B
YUHAN CORPORATION	+1.87%	+2.46%	-37.23%	+24.94%	3.48B
SUPERNUS PHARMACEUTICALS, INC.	+0.54%	-1.34%	+43.48%	+63.42%	2.77B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-0.81%	+8.11%	+14.84%	-16.29%	2.28B
Average	+0.07%	-2.93%	+8.13%	+12.64%	40.94B
Weighted average by Cap.	+2.55%	-4.79%	+46.59%	+17.72%